Zeige Ergebnisse 111 - 120 von 372
2015
Müller, R., Hartmann, R. W., Kirschning, A., Weiss, S., Tegge, W., & Häussler, S. (2015). Biofilm-Inhibitoren: Entwicklung von Inhibitoren zur Prävention und Behandlung von Biofilmen humanpathogener Bakterien: Abschlussbericht: Laufzeit des Vorhabens: 01.02.2012-31.01.2015. Twincore Zentrum für Experimentelle und Klinische Infektionsforschung. https://edocs.tib.eu/files/e01fb16/857120247.pdf
Moreno, M., Elgaher, W. A. M., Herrmann, J., Schläger, N., Hamed, M. M., Baumann, S., Müller, R., Hartmann, R. W., & Kirschning, A. (2015). Synthesis and biological evaluation of cystobactamid 507: A bacterial topoisomerase inhibitor from Cystobacter sp. Synlett, 26(9), 1175-1178. Artikel st-2015-b0058-l. https://doi.org/10.1055/s-0034-1380509
Stumpp, N., Premnath, P., Schmidt, T., Ammermann, J., Dräger, G., Reck, M., Jansen, R., Stiesch, M., Wagner-Döbler, I., & Kirschning, A. (2015). Synthesis of new carolacton derivatives and their activity against biofilms of oral bacteria. Organic and Biomolecular Chemistry, 13(20), 5765-5774. https://doi.org/10.1039/c5ob00460h
Kirschning, A., & Reydon, T. A. C. (2015). Is organic chemistry science: And does this question make any sense at all? Beilstein Journal of Organic Chemistry, 11, 893-896. https://doi.org/10.3762/bjoc.11.100
Jürjens, G., Kirschning, A., & Candito, D. A. (2015). Lessons from the Synthetic Chemist Nature. Natural Product Reports, 32(5), 723-737. https://doi.org/10.1039/c4np00160e
Breznica-Selmani, P., Mladenovska, K., Kavrakovski, Z., Mikhova, B., Draeger, G., & Popovski, E. (2015). [(3-Chlorobenzamido)methyl]triethylammonium chloride. MolBank, 2015(2). https://doi.org/10.3390/M851
Williams, S., Neumann, A., Bremer, I., Su, Y., Dräger, G., Kasper, C., & Behrens, P. (2015). Nanoporous silica nanoparticles as biomaterials: evaluation of different strategies for the functionalization with polysialic acid by step-by-step cytocompatibility testing. Journal of Materials Science: Materials in Medicine, 26(3). https://doi.org/10.1007/s10856-015-5409-3
Franke, J., Bock, M., Dehn, R., Fohrer, J., Mhaske, S. B., Migliorini, A., Kanakis, A. A., Jansen, R., Herrmann, J., Müller, R., & Kirschning, A. (2015). Total and semi-syntheses of antimicrobial thuggacin derivatives. Chemistry - A European Journal, 21(11), 4272-4284. https://doi.org/10.1002/chem.201405874
Hermane, J., Bułyszko, I., Eichner, S., Sasse, F., Collisi, W., Poso, A., Schax, E., Walter, J. G., Scheper, T., Kock, K., Herrmann, C., Aliuos, P., Reuter, G., Zeilinger, C., & Kirschning, A. (2015). New, Non‐quinone Fluorogeldanamycin Derivatives Strongly Inhibit Hsp90. CHEMBIOCHEM, 16(2), 302-311. https://doi.org/10.1002/cbic.201402375
Kirschning, A., Walter, J., Stahl, F., Schax, E., Scheper, T., Aliuos, P., & Zeilinger, C. (2015). Molecular Survival Strategies of Organisms: HSP and Small Molecules for Diagnostics and Drug Development. In Heat Shock Protein-Based Therapies (Heat Shock Proteins; Band 9). https://doi.org/10.1007/978-3-319-17211-8_16
